Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival

November 20, 2012 | Comments Off on Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival

Anticancer Research. 2012 Nov;32(11):5071-4. [Link] Lumachi F, Mazza F, Ermani M, Chiara GB, Basso SM. Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, School of Medicine, Via…

Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results

November 20, 2012 | Comments Off on Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results

Anticancer Research. 2012 Nov;32(11):5131-4. [Link] Basso SM, Mazza F, Marzano B, Santeufemia DA, Chiara GB, Lumachi F. Surgey I, S. Maria degli Angeli Hospital, Via Montereale 24, 33170 Pordenone, Italy.…

Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma

January 26, 2011 | Comments Off on Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma

Journal of Thoracic Oncology. 2011 Mar;6(3):602-5. [Link] Kao SC, Yan TD, Lee K, Burn J, Henderson DW, Klebe S, Kennedy C, Vardy J, Clarke S, van Zandwijk N, McCaughan BC.…

Targeted therapies in malignant pleural mesothelioma: a review of clinical studies

January 26, 2011 | Comments Off on Targeted therapies in malignant pleural mesothelioma: a review of clinical studies

Anticancer Drugs. 2011 Mar;22(3):199-205. [Link] Greillier L, Marco S, Barlesi F. Service d’Oncologie Multidisciplinaire et Innovations Thérapeutiques, Université de la Méditerranée-Assistance Publique Hôpitaux de Marseille, Marseille, France. Abstract Malignant pleural…

Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin

January 25, 2011 | Comments Off on Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin

Clinical Cancer Research. 2011 Apr 15;17(8):2581-90. Epub 2011 Jan 24. [Link] Zucali PA, Giovannetti E, Destro A, Mencoboni M, Ceresoli GL, Gianoncelli L, Lorenzi E, De Vincenzo F, Simonelli M,…

Thoracoscopic extrapleural pneumonectomy for mesothelioma

January 25, 2011 | Comments Off on Thoracoscopic extrapleural pneumonectomy for mesothelioma

The Annals of thoracic surgery. 2011 Feb;91(2):616-8. [Link] Demmy TL, Platis IE, Nwogu C, Yendamuri S. Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, New York. Abstract Mesothelioma is…

Antioxidants Prevent the RhoA Inhibition Evoked by Crocidolite Asbestos in Human Mesothelial and Mesothelioma Cells

January 25, 2011 | Comments Off on Antioxidants Prevent the RhoA Inhibition Evoked by Crocidolite Asbestos in Human Mesothelial and Mesothelioma Cells

American Journal of Respiratory Cell and Molecular Biology. 2011 Jan 21. [Epub ahead of print] [Link] Aldieri E, Riganti C, Silvagno F, Orecchia S, Betta PG, Doublier S, Gazzano E,…

miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer

January 25, 2011 | Comments Off on miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer

Journal of Thoracic Oncology. 2011 Jan 20. [Epub ahead of print] [Link] Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. *Translational Genomics Research Institute, Phoenix, Arizona;…

Occupational Respiratory Cancer in Korea

January 25, 2011 | Comments Off on Occupational Respiratory Cancer in Korea

Journal of Korean Medical Science. 2010 Dec;25(Suppl):S94-S98. Epub 2010 Dec 15. [Link] Lee HE, Kim HR. Occupational Safety and Health Research Institute, KOSHA, Inchoen, Korea. Abstract Malignant mesothelioma and lung…

LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma

January 20, 2011 | Comments Off on LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma

Cancer Research. 2011 Jan 18. [Epub ahead of print] [Link] Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, Akatsuka S, Horio Y, Hida T, Kondo Y,…

Categories